Literature DB >> 8882599

Regulation of the human histamine H1 receptor stably expressed in Chinese hamster ovary cells.

M J Smit1, H Timmerman, J C Hijzelendoorn, H Fukui, R Leurs.   

Abstract

1. The human H1 receptor gene expressed in Chinese hamster ovary cells (CHOhumH1) encodes a classical histamine H1 receptor with a pharmacology similar to that of the H1 receptor found in guinea-pig cerebellum and the endogenously expressed human H1 receptor in 1321N1 astrocytoma cells as determined by [3H]-mepyramine binding studies. 2. In CHOhumH1 cells, histamine induced a concentration-dependent rise in inositol phosphates (EC50 2.23 +/- 0.97 microM) and a rapid increase of [Ca2+]i, followed by a sustained increase of [Ca2+]i upon addition of 100 microM histamine. 3. Short-term exposure of CHOhumH1 cells to histamine (100 microM) resulted in a decrease of subsequent histamine-induced Ca2+ responses. The histamine-induced desensitization appeared to be heterologous as the ATP-induced Ca2+ response was also found to be affected. 4. The process of heterologous histamine-induced desensitization of the Ca2+ response in CHOhumH1 cells can be ascribed to an alteration at the level of the intracellular Ca2+ pool, as the Ca2+ response of caffeine (10 mM), which releases Ca2+ from intracellular Ca2+ stores was also attenuated upon short-term histamine exposure. 5. In CHOhumH1 cells the PKC activator, PMA, was found to inhibit the histamine (100 microM)-induced Ca2+ response concentration-dependently (IC50 0.2 +/- 0.03 microM) as well as the ATP (100 microM)-induced Ca2+ response. However, this inhibition was only partial and less effective than histamine-pretreatment. Moreover, in CHOhumH1 cells PKC downregulation induced by long-term exposure to PMA (1 microM) did not affect the histamine-induced desensitization nor did pretreatment with the specific PKC inhibitor Ro-31-8220 (10 microM), indicating that in CHOhumH1 cells PKC is probably not involved in the heterologous desensitization. 6. Long-term treatment of CHOhumH1 cells with histamine or other H1 agonists resulted in a time- and concentration-dependent decrease in the number of H1 receptor binding sites (maximal reduction: 47 +/- 5%). 7. Long-term exposure of CHOhumH1 cells to ATP or PMA did not affect H1 receptor density. 8. Both histamine (100 microM)- and ATP (100 microM)-induced Ca2+ responses were affected upon long-term exposure of cells to histamine (100 microM), which might be explained by an alteration at a level distant from the receptor. 9. These results show that in CHOhumH1 cells the human histamine H1 receptor is susceptible to short-term and long-term receptor regulation in which PKC does not seem to play a role. The CHOhumH1 cells therefore provide an excellent model system for studying the mechanism(s) of PKC-independent H1 receptor regulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882599      PMCID: PMC1909783          DOI: 10.1111/j.1476-5381.1996.tb16699.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  Short-term desensitization of the histamine H1 receptor in human HeLa cells: involvement of protein kinase C dependent and independent pathways.

Authors:  M J Smit; S M Bloemers; R Leurs; L G Tertoolen; A Bast; S W de Laat; H Timmerman
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

2.  Inositol 1,4,5-trisphosphate receptor immunoreactivity in SH-SY5Y human neuroblastoma cells is reduced by chronic muscarinic receptor activation.

Authors:  R J Wojcikiewicz; S Nakade; K Mikoshiba; S R Nahorski
Journal:  J Neurochem       Date:  1992-07       Impact factor: 5.372

3.  Genomic cloning of the rat histamine H1 receptor.

Authors:  K Fujimoto; Y Horio; K Sugama; S Ito; Y Q Liu; H Fukui
Journal:  Biochem Biophys Res Commun       Date:  1993-01-15       Impact factor: 3.575

4.  Molecular cloning of the guinea-pig histamine H1 receptor gene.

Authors:  Y Horio; Y Mori; I Higuchi; K Fujimoto; S Ito; H Fukui
Journal:  J Biochem       Date:  1993-09       Impact factor: 3.387

5.  Is there a difference in the affinity of histamine H1 receptor antagonists for CNS and peripheral receptors? An in vitro study.

Authors:  A M Ter Laak; G M Donné-Op den Kelder; A Bast; H Timmerman
Journal:  Eur J Pharmacol       Date:  1993-03-02       Impact factor: 4.432

6.  Histamine H1 receptors in complex partial seizures.

Authors:  K Iinuma; H Yokoyama; T Otsuki; K Yanai; T Watanabe; T Ido; M Itoh
Journal:  Lancet       Date:  1993-01-23       Impact factor: 79.321

7.  Age-dependent decrease in histamine H1 receptor in human brains revealed by PET.

Authors:  K Yanai; T Watanabe; K Meguro; H Yokoyama; I Sato; H Sasano; M Itoh; R Iwata; T Takahashi; T Ido
Journal:  Neuroreport       Date:  1992-05       Impact factor: 1.837

8.  Desensitization of histamine H1 receptor-mediated inositol phosphate accumulation in guinea pig cerebral cortex slices.

Authors:  D R Bristow; P C Banford; I Bajusz; A Vedat; J M Young
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

9.  Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cells.

Authors:  S Gucker; J M Bidlack
Journal:  Mol Pharmacol       Date:  1992-10       Impact factor: 4.436

10.  Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor.

Authors:  M D De Backer; W Gommeren; H Moereels; G Nobels; P Van Gompel; J E Leysen; W H Luyten
Journal:  Biochem Biophys Res Commun       Date:  1993-12-30       Impact factor: 3.575

View more
  7 in total

1.  Agonist-promoted homologous desensitization of human airway smooth muscle bitter taste receptors.

Authors:  Kathryn S Robinett; Deepak A Deshpande; Molly M Malone; Stephen B Liggett
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-03       Impact factor: 6.914

2.  Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptors.

Authors:  R J Slack; L J Russell; D A Hall; M A Luttmann; A J Ford; K A Saunders; S T Hodgson; H E Connor; C Browning; K L Clark
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

Review 3.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

Review 4.  Molecular Signaling and Transcriptional Regulation of Histamine H1 Receptor Gene.

Authors:  Hiroyuki Mizuguchi; Yoshiaki Kitamura; Noriaki Takeda; Hiroyuki Fukui
Journal:  Curr Top Behav Neurosci       Date:  2022

5.  The Novel Pimavanserin Derivative ST-2300 with Histamine H3 Receptor Affinity Shows Reduced 5-HT2A Binding, but Maintains Antidepressant- and Anxiolytic-like Properties in Mice.

Authors:  Karthikkumar Venkatachalam; Sicheng Zhong; Mariam Dubiel; Grzegorz Satała; Bassem Sadek; Holger Stark
Journal:  Biomolecules       Date:  2022-05-10

6.  Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice.

Authors:  Rajkumar Noubade; Graeme Milligan; James F Zachary; Elizabeth P Blankenhorn; Roxana del Rio; Mercedes Rincon; Cory Teuscher
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

7.  Reducing Auditory Nerve Excitability by Acute Antagonism of Ca2+-Permeable AMPA Receptors.

Authors:  Amit Walia; Choongheon Lee; Jared Hartsock; Shawn S Goodman; Roland Dolle; Alec N Salt; Jeffery T Lichtenhan; Mark A Rutherford
Journal:  Front Synaptic Neurosci       Date:  2021-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.